MTAP homozygous deletion: an Achilles heel of human cancers ready for clinical use?
Capella
Gabriel
G
IDIBELL-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain.
Caldas
Carlos
C
D000249:Adenosine Monophosphate / Q000378:metabolism; D000409:Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D017353:Gene Deletion; D006720:Homozygote; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011683:Purine-Nucleoside Phosphorylase / Q000235:genetics*
D000903:Antibiotics, Antineoplastic; C000082:alanosine; D000249:Adenosine Monophosphate; D011683:Purine-Nucleoside Phosphorylase; C021784:5'-methylthioadenosine phosphorylase; D000409:Alanine